- Home
- CHRS vs MVST Comparison
CHRS vs MVST Comparison
Compare CHRS & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- MVST
- Stock Information
- Founded
- CHRS 2010
- MVST 2006
- Country
- CHRS United States
- MVST United States
- Employees
- CHRS N/A
- MVST N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- MVST Industrial Machinery/Components
- Sector
- CHRS Health Care
- MVST Miscellaneous
- Exchange
- CHRS Nasdaq
- MVST Nasdaq
- Market Cap
- CHRS 84.2M
- MVST 1.3B
- IPO Year
- CHRS 2014
- MVST N/A
- Fundamental
- Price
- CHRS $0.82
- MVST $3.61
- Analyst Decision
- CHRS Buy
- MVST Strong Buy
- Analyst Count
- CHRS 3
- MVST 1
- Target Price
- CHRS $4.68
- MVST $3.00
- AVG Volume (30 Days)
- CHRS 1.3M
- MVST 9.2M
- Earning Date
- CHRS 08-07-2025
- MVST 08-07-2025
- Dividend Yield
- CHRS N/A
- MVST N/A
- EPS Growth
- CHRS N/A
- MVST N/A
- EPS
- CHRS N/A
- MVST N/A
- Revenue
- CHRS $272,251,000.00
- MVST $414,941,000.00
- Revenue This Year
- CHRS N/A
- MVST $26.08
- Revenue Next Year
- CHRS $106.56
- MVST $29.71
- P/E Ratio
- CHRS $1.90
- MVST N/A
- Revenue Growth
- CHRS 19.87
- MVST 21.68
- 52 Week Low
- CHRS $0.66
- MVST $0.15
- 52 Week High
- CHRS $2.43
- MVST $4.72
- Technical
- Relative Strength Index (RSI)
- CHRS 53.65
- MVST 47.09
- Support Level
- CHRS $0.72
- MVST $3.42
- Resistance Level
- CHRS $0.77
- MVST $4.27
- Average True Range (ATR)
- CHRS 0.04
- MVST 0.32
- MACD
- CHRS 0.01
- MVST -0.12
- Stochastic Oscillator
- CHRS 91.74
- MVST 13.85
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.